1. Gelman N, Gorell JM, Barker PB, Savage RM, Spickler EM, Windham JP, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology. 1999; 210:759–767. PMID:
10207479.
Article
2. Kurian MA, McNeill A, Lin JP, Maher ER. Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol. 2011; 53:394–404. PMID:
21480873.
Article
3. Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet. 2009; 46:73–80. PMID:
18981035.
Article
4. Schneider SA, Hardy J, Bhatia KP. Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord. 2012; 27:42–53. PMID:
22031173.
Article
5. Gregory A, Hayflick SJ. Pantothenate kinase-associated neurodegeneration. In : Adam MP, Ardinger HH, Pagon RA, Wallace SE, editors. GeneReviews. Seattle: University of Washington;1993.
6. Graham HK, Aoki KR, Autti-Ramo I, Boyd RN, Delgado MR, Gaebler-Spira DJ, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture. 2000; 11:67–79. PMID:
10664488.
Article
7. Egan RA, Weleber RG, Hogarth P, Gregory A, Coryell J, Westaway SK, et al. Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). Am J Ophthalmol. 2005; 140:267–274. PMID:
16023068.
Article
8. Seo JH, Song SK, Lee PH. A novel PANK2 mutation in a patient with atypical pantothenate-kinase-associated neurodegeneration presenting with adult-onset Parkinsonism. J Clin Neurol. 2009; 5:192–194. PMID:
20076801.
Article
9. Crisci C, Esposito M. Efficacy of botulinum toxin A treatment in a case of pantothenate kinase associated neurodegeneration (PKAN). BMJ Case Rep. 2011; 5. 16. [Epub]. DOI:
10.1136/bcr.07.2011.4514.
Article
10. Rai V, Goyal V, Shukla G, Rath G, Behari M. Adductor laryngeal breathing dystonia in NBIA treated with botulinum toxin-A. Ann Indian Acad Neurol. 2013; 16:409–410. PMID:
24101831.
Article